Barr Preparing Seasonale Ultra-Lo, DP3 Submissions For 2005

Barr appears to have delayed submission of Seasonale Ultra-Lo because of its poor performance in the pivotal trial for Barr’s extended-cycle oral contraceptive, FDA’s review documents for Seasonale suggest.